Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

Related Articles by Review for PubMed (Select 16175106)

1.

ADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label study.

Wilens T, McBurnett K, Stein M, Lerner M, Spencer T, Wolraich M.

J Am Acad Child Adolesc Psychiatry. 2005 Oct;44(10):1015-23. Erratum in: J Am Acad Child Adolesc Psychiatry. 2006 May;45(5):632.

PMID:
16175106
2.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
3.

OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.

Ramos-Quiroga JA, Corominas M, Castells X, Bosch R, Casas M.

Expert Rev Neurother. 2009 Aug;9(8):1121-31. doi: 10.1586/ern.09.65. Review.

PMID:
19673602
4.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

5.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
6.

Osmotic, controlled-release methylphenidate for the treatment of ADHD.

Coghill D, Seth S.

Expert Opin Pharmacother. 2006 Oct;7(15):2119-38. Review.

PMID:
17020437
7.
8.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
9.

An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy.

Baptista-Neto L, Dodds A, Rao S, Whitney J, Torres A, Gonzalez-Heydrich J.

Expert Opin Investig Drugs. 2008 Jan;17(1):77-84. Review.

PMID:
18095920
10.

OROS methylphenidate hydrochloride for adult patients with attention deficit/hyperactivity disorder.

McBurnett K, Starr HL.

Expert Opin Pharmacother. 2011 Feb;12(2):315-24. doi: 10.1517/14656566.2011.546058. Review.

PMID:
21226641
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk